TCT 2020 | Initial Studies Show Incredible Results with Lithotripsy in Calcified Lesions

Intravascular coronary lithotripsy shows promise for the improvement of angioplasty in severely calcified lesions, according to data from the DISRUPT CAD III study, published in JACC and simultaneously presented at the TCT 2020 Congress.

Calcification in all patients enrolled was highly severe, with an average length of 48 mm, and side-branch involvement in 30% of cases.

Lithotripsy, which involves using acoustic pressure waves to fracture calcium, was well tolerated with low rates of complications.

Observed results were confirmed by pre- and post-procedure intravascular imaging.

DISRUPT CAD III enrolled 431 patients in 47 sites presenting severely calcified de novo coronary artery lesions with reference diameters between 2.5 mm and 4.0 mm.


Read also: TCT 2020 | Fewer Symptoms and Events when Optimizing with iFR.


The primary safety endpoint was observed in 92.2% of patients. Similarly, the effectiveness endpoint occurred in 92.4%. Both endpoints exceeded expectations.

Previous reports indicated the possibility of ventricular capture with shock waves, something that was observed in this study. Said captures were not associated with sustained ventricular arrhythmias during or immediately after the procedure, and they did not correlate with adverse events either.

Conclusion

Coronary lithotripsy was safe and effective in facilitating stent implantation and expansion in highly calcified lesions.

DISRUPT-CAD-III

Original Title: Intravascular lithotripsy for treatment of severely calcified coronary artery disease: the DISRUPT CAD III study.

Reference: Hill JM et al. J Am Coll Cardiol. 2020; Epub ahead of print y presentado simultáneamente en el congreso TCT 2020 virtual.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....